Physician profile
William A Huff
NPI 1790882777
$3,115.93
in general payments reported to CMS, 2019-2025
18 companies · $827 in 2025
The $827 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2020: $858 · 2021: $240 · 2022: $684 · 2023: $126 · 2024: $241 · 2025: $827.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $717 · Food and Beverage: $477.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $717.21 |
| Food and Beverage | $476.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $953.01 | 2019-2025 | Mako |
| Southtech Orthopedics | $824.80 | 2020 | |
| Si-Bone, INC. | $641.06 | 2022-2024 | |
| Horizon Therapeutics Plc | $191.35 | 2019-2022 | |
| Fidia Pharma USA INC. | $124.90 | 2019-2023 | Hymovis, Triluron |
| Zimmer Biomet Holdings, INC. | $106.09 | 2022-2024 | Persona |
| Smith+Nephew, INC. | $45.77 | 2021-2022 | |
| Bioventus LLC | $37.46 | 2023-2024 | Durolane, Exogen Ultrasound Bone Healing System |
| Sanofi-Aventis U.S. LLC | $31.98 | 2019-2022 | |
| Amgen INC. | $31.40 | 2024 | Krystexxa |
| Davol INC. | $23.61 | 2021 | |
| Pacira Therapeutics, INC. | $21.75 | 2021 | |
| Depuy Synthes Sales INC. | $16.19 | 2023 | Orthovisc |
| Organogenesis INC. | $15.29 | 2019 | |
| Becton, Dickinson and Company | $13.57 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $12.88 | 2022 | |
| Heraeus Medical, LLC. | $12.41 | 2023 | Palacos |
| Orthogenrx INC. | $12.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Huff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.